While subsequent fine mapping studies have identified several genes as being candidate susceptibility markers in this locus, including SASH1, RGS17, and EYA4 [99–101], limited progress has been made to comprehensively characterize these genes as independent or cooperative tumor suppressor genes with a hereditary and prognostic role in lung cancer development. The gene discussed is RGS17; the disease is lung cancer.